Leanne Kelly
CIK 1398278 · Chief Financial Officer · last filed 2025-09-22
Leanne Kelly is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for GRI, was dated Sep 22, 2025. Across all open-market trades the lifetime net is +$25.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
12
$25.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GRI | Chief Financial Officer | — | $2.25 | — | $0 | 4 | 2025-09-22 |
| GRI Bio, Inc. (VLON) Delisted | Chief Financial Officer | 6,250 | $12.00 | $75.0K | $25.2K | 3 | 2022-03-01 |
| GENAERA CORP (GENR) Delisted | SVP & Chief Financial Officer | 2,183 | — | — | $0 | 4 | 2008-08-13 |
| GENAERA CORP (GENRD) Delisted | Sr. Vice President & CFO | — | — | — | $0 | 1 | 2007-05-22 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-22 | GRI | Grant (A) | — | $0 | EDGAR |
| 2025-08-27 | GRI | Grant (A) | — | $0 | EDGAR |
| 2025-01-24 | GRI | Grant (A) | — | $0 | EDGAR |
| 2023-09-26 | GRI | Grant (A) | — | $0 | EDGAR |
| 2022-03-01 | GRI Bio, Inc. (VLON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | GRI Bio, Inc. (VLON) Delisted | Buy (P) | +6,250 | $25.2K | EDGAR |
| 2021-05-18 | GRI Bio, Inc. (VLON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-08-13 | GENAERA CORP (GENR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-18 | GENAERA CORP (GENR) Delisted | Exer (M) | +417 | $0 | EDGAR |
| 2007-09-28 | GENAERA CORP (GENR) Delisted | Grant (A) | — | $0 | EDGAR |